Inventor
SCHINDLER MARCUS
DE16 patents
⚠️ This page may combine multiple inventors who share the name “SCHINDLER MARCUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
4 patentsUS7592373B2Sep 22, 2009
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM INT13 citations84
US7605176B2Oct 20, 2009
β-ketoamide compounds with MCH antagonistic activity
BOEHRINGER INGELHEIM INT2 citations52
US7592358B2Sep 22, 2009
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM INT2 citations52
US7524862B2Apr 28, 2009
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
BOEHRINGER INGELHEIM INT1 citations52
BOEHRINGER INGELHEIM PHARMA
4 patentsUS7026312B2Apr 11, 2006
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
BOEHRINGER INGELHEIM PHARMA8 citations73
US7595312B2Sep 29, 2009
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA3 citations62
US7538115B2May 26, 2009
Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
BOEHRINGER INGELHEIM PHARMA4 citations62
US7700589B2Apr 20, 2010
CGRP antagonists
BOEHRINGER INGELHEIM PHARMA0 citations41
SPROUT PHARMACEUTICALS INC
3 patentsUS9730927B2Aug 15, 2017
Use of flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC2 citations72
US10874668B2Dec 29, 2020
Use of Flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC0 citations51
US10335407B2Jul 2, 2019
Use of flibanserin in the treatment of obesity
SPROUT PHARMACEUTICALS INC0 citations51